AC
GOSS icon

AXQ Capital’s Gossamer Bio GOSS Stock Holding History

AXQ Capital’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71K Sell
20,421
-42,696
-68% -$67.1K ﹤0.01% 973
2025
Q4 		$196K Buy
63,117
+16,750
+36% +$47.8K 0.04% 574
2025
Q3 		$122K Buy
+46,367
New +$102K 0.05% 502
2023
Q1 		– Sell
-16,372
Closed -$35.5K – 543
2022
Q4 		$35.5K Buy
+16,372
New +$135K 0.02% 313

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

AXQ Capital's GOSS Position: Q1 2026 in Review

AXQ Capital reduced its Gossamer Bio (GOSS) stake by 68% in Q1 2026, selling an estimated $67.1K and leaving 20,421 shares worth $6.71K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

AXQ Capital first reported a position in GOSS in Q4 2022 and has held it in 4 quarters since. The position peaked at $196K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • AXQ Capital held 20,421 shares of Gossamer Bio worth $6.71K as of Q1 2026.
  • AXQ Capital sold 42,696 Gossamer Bio shares in Q1 2026, an estimated $67.1K.
  • Gossamer Bio made up ﹤0.01% of AXQ Capital's portfolio in Q1 2026, its #973 holding.
  • AXQ Capital first reported a position in Gossamer Bio in Q4 2022 and has held it in 4 quarters since.
  • AXQ Capital's Gossamer Bio position peaked at $196K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.